Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
What changed in glaucoma care in 2025: Surgeon perspective | Ophthalmology Times
In a year-end conversation, Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas, in Dallas, sat down with the Eye Care Network to reflect on how glaucoma care evolved as 2025 drew to a close. Framing the discussion as a…
Global trial equity: How LMIC data is reshaping US ophthalmology research | Ophthalmology Times
Incorporating data from low- and middle-income countries may help redefine how ophthalmology trials are designed, evaluated, and applied in practice (Image credit: AdobeStock/PUTRABATARA) Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins…
Comparing Aflibercept 8 mg and Faricimab in RVO | Ophthalmology Times
In this segment, the panel compares the pivotal QUASAR trial of aflibercept 8 mg in retinal vein occlusion (RVO) with the BALATON and COMINO trials evaluating faricimab. They note that all three studies demonstrated robust visual and anatomic improvements—typically gains…
Insights from Privotal Trials for Aflibercept (8 mg) in RVO | Ophthalmology Times
This segment explores emerging data on aflibercept 8 mg for retinal vein occlusion (RVO) and the evolving understanding of disease chronicity under anti-VEGF therapy. The panelists discuss the pivotal QUASAR trial, which uniquely combined CRVO and BRVO populations and demonstrated…
Achieving a new level of refractive precision: Surgical strategies | Ophthalmology Times
(Image Credit: AdobeStock) Even the most experienced cataract surgeons—armed with advanced diagnostic technologies, modern IOL power calculation formulas, and a meticulous surgical technique—encounter patients whose vision does not reach the intended refraction. A prospective analysis of about 9000 routine cataract…
FDA approvals in 2025: What changed and why it matters for ophthalmologists | Ophthalmology Times
Editor’s Note: This content was generated with the assistance of AI. From first-in-class pharmacologic therapies to next-generation retinal durability strategies and less invasive surgical platforms, 2025 emerged as a pivotal year for the ophthalmic pipeline. Over the past 12 months,…
Q&A: What changed in residency education in 2025? Perspectives from training directors | Ophthalmology Times
Residency programs are adapting to evolving training requirements, new technologies, and changing trainee needs to better prepare future ophthalmologists. (Image credit: AdobeStock/WavebreakMediaMicro) Ophthalmology residency training is constantly evolving, and 2025 marked a year of notable developments that are shaping how…
PRIMAvera study: Central vision improvement with subretinal implant | Ophthalmology Times
The implant is shown placed subretinally in an eye with geographic atrophy due to age-related macular degeneration. (Image courtesy of Frank G. Holz, MD, FEBO, FARVO) (PRIMA) system implant restored central vision and led to a significant improvement in visual…
Reflections from the floor: AAO memories that shaped careers | Ophthalmology Times
Ophthalmology conferences are often remembered not just for scientific sessions or new technologies, but for the personal encounters that quietly shape careers in ophthalmology. For many physicians, these meetings serve as milestones—marking transitions from trainee to practitioner, introductions to mentors,…
Refractory dry eye care: How systemic conditions change the game | Ophthalmology Times
Sezen Karakus, MD, discusses strategies for managing refractory dry eye in patients with systemic conditions, highlighting diagnosis, systemic coordination, and emerging treatment options. (Image credit: AdobeStock/Антон Сальников) Refractory dry eye in patients with systemic comorbidities can be challenging to manage…